Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Vivos Therapeutics, Inc.

Market Cap 6.95M 6.06M 5.61M 5.25M 9.85M 656M 9.91M 66.55M 25.79M 323M 26.08M 25.52M 1.12B P/E 2026 *
-0.27x
P/E 2027 * -0.6x
Enterprise Value 6.95M 6.06M 5.61M 5.25M 9.85M 656M 9.91M 66.55M 25.79M 323M 26.08M 25.52M 1.12B EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.2x
Free-Float
74.28%
Yield 2026 *
-
Yield 2027 * -
1 day-2.19%
1 week-12.59%
Current month-28.57%
1 month-15.25%
3 months-59.02%
6 months-74.62%
Current year-75.37%
1 week 0.45
Extreme 0.45
0.58
1 month 0.45
Extreme 0.45
1.36
Current year 0.45
Extreme 0.45
2.69
1 year 0.45
Extreme 0.45
7.95
3 years 0.45
Extreme 0.45
48.79
5 years 0.45
Extreme 0.45
177.25
10 years 0.45
Extreme 0.45
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 2016-08-31
Chief Executive Officer 68 2016-08-31
Director TitleAgeSince
Chairman 68 2020-05-31
Director/Board Member 87 2020-05-31
Director/Board Member 59 2020-05-31
Date Insider Type Main position Quantity % Market Cap.
02-03Other

Director

3,997 0.0424%
24-11-25Other

Chief Executive Officer

315,421 6.6191%
24-11-25Other

Chief Financial Officer

149,533 3.1380%
Change 5-day change 1-year change 3-year change Capi.($)
-2.19%-12.59%-82.14%-96.06% 6.95M
+0.33%-0.47%+23.49%-6.09% 12.48B
-1.61%-3.93%+52.52%+24.03% 5.75B
+0.23%-1.20%+6.10%+0.65% 5.51B
+4.23%-2.57% - - 4.15B
-2.42%-6.52%-30.18%+11.61% 4B
-2.06%-4.78%-29.65%-28.86% 3.65B
+3.49%+6.69%+56.28%+255.43% 1.84B
-20.00%-19.69%-14.44%-67.62% 1.65B
-0.37%-1.59%+60.47%-7.57% 1.53B
Average -2.04%-4.45%+4.72%+9.50% 4.06B
Weighted average by Cap. -0.76%-2.11%+15.69%+9.69%

Financials

2026 *2027 *
Net sales 23.12M 20.16M 18.67M 17.48M 32.78M 2.18B 32.98M 221M 85.84M 1.07B 86.79M 84.93M 3.73B 34.51M 30.09M 27.87M 26.09M 48.93M 3.26B 49.22M 331M 128M 1.6B 130M 127M 5.57B
Net income -27.35M -23.85M -22.09M -20.67M -38.77M -2.58B -39.01M -262M -102M -1.27B -103M -100M -4.41B -13.85M -12.08M -11.19M -10.47M -19.64M -1.31B -19.76M -133M -51.43M -643M -52M -50.88M -2.23B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
26-06-18 0.5000 $ -2.19% 500,604
26-06-17 0.5112 $ -6.12% 724,528
26-06-16 0.5445 $ -5.68% 283,083
26-06-15 0.5773 $ +0.93% 397,001
26-06-12 0.5720 $ -6.79% 281,398
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5000USD
Average target price
2.450USD
Spread / Average Target
+390.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!